
LINK . SPRINGER . COM {
}
Title:
Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart | Cardiovascular Drugs and Therapy
Description:
The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Education
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, pubmed, google, scholar, cas, angiotensin, receptor, heart, cardiac, cardiovasc, wang, glp, liraglutide, linagliptin, physiol, peptide, cardiovascular, drugs, myocardial, glucagonlike, fibrosis, central, iiinduced, angiotensinconverting, enzyme, control, collagen, ther, university, shanxi, privacy, cookies, content, research, tissue, expression, zhao, ang, ace, access, fibroblasts, inhibitors, res, inflammation, remodeling, circ, medicine, publish, search, preservation,
Topics {✒️}
ii-induced cardiac fibrosis zhi-qing zhao angiotensin-converting enzyme inhibitors month download article/chapter locally-expressed at1 receptor related subjects 288 ± 19 rfu/min/μg protein repressing nuclear factor-kappa transforming growth factor-beta1 smaller collagen-rich area reduced at1/at2 ratio α-sma expressing myofibroblasts xue-fen pang ning-ping wang dipeptidyl peptidase-4 inhibitors xue-wen li extracellular signal-regulated kinase ameliorates cardiac dysfunction myocardial ischemia-reperfusion injury full article pdf article cardiovascular drugs chronic heart failure angiotensin ii revisited diet-induced obesity ahmed ijaz shah angiotensin receptor blockers experimental heart failure at2 receptors privacy choices/manage cookies ang ii infusion cardioprotective effects mediated exert cardioprotective effects protein level mol cell cardiol enhanced at2 receptor article zhang dipeptidyl peptidase-4 improve coronary haemodynamics glp-1 receptor expression glp-1 receptor localization renin-angiotensin system tissue fibrosis peptide-1 access smad-dependent pathways myocardial ischemia/reperfusion cardiac fibrosis european economic area physiol endocrinol metab pressure dependent ischemic heart disease
Schema {🗺️}
WebPage:
mainEntity:
headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
datePublished:2015-05-21T00:00:00Z
dateModified:2015-05-21T00:00:00Z
pageStart:243
pageEnd:255
sameAs:https://doi.org/10.1007/s10557-015-6592-7
keywords:
Angiotensin II receptors
ACE2
Collagen
Cardiac fibrosis
Dipeptidyl peptidase-4
Glucagon-like peptide-1
Cardiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
isPartOf:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
type:Person
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
datePublished:2015-05-21T00:00:00Z
dateModified:2015-05-21T00:00:00Z
pageStart:243
pageEnd:255
sameAs:https://doi.org/10.1007/s10557-015-6592-7
keywords:
Angiotensin II receptors
ACE2
Collagen
Cardiac fibrosis
Dipeptidyl peptidase-4
Glucagon-like peptide-1
Cardiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
isPartOf:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
type:Person
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(151)
- What's the financial intake of https://www.springernature.com/gp/authors?
- What's the financial outcome of https://link.springernature.com/home/?
- What are the total earnings of https://order.springer.com/public/cart?
- How much does https://www.editorialmanager.com/cdty/ pull in?
- How much revenue does https://www.springernature.com/gp/librarians/licensing/agc/journals generate?
- Learn how profitable https://doi.org/10.1016%2Fj.jacc.2011.08.034 is on a monthly basis
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22115639's revenue stream
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Repair%20after%20myocardial%20infarction%20between%20fantasy%20and%20reality&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2Fj.jacc.2011.08.034&volume=58&pages=2357-2362&publication_year=2011&author=Liehn%2CEA&author=Postea%2CO&author=Curaj%2CA&author=Marx%2CN
- https://doi.org/10.1097%2F00004872-200401000-00011's financial summary
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15106793's total income per month
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Fibrosis%20in%20hypertension%20heart%20disease%3A%20focus%20on%20cardiac%20fibroblasts&journal=J%20Hypertens&doi=10.1097%2F00004872-200401000-00011&volume=22&pages=47-60&publication_year=2004&author=Weber%2CKT
- What is the earnings of https://doi.org/10.1016%2Fj.ahj.2012.02.016?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22607854's revenue stream
- Income figures for http://scholar.google.com/scholar_lookup?&title=Angiotensin%20converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20for%20treatment%20of%20ischemic%20heart%20disease%3A%20future%20research%20needs%20prioritization&journal=Am%20Heart%20J&doi=10.1016%2Fj.ahj.2012.02.016&volume=163&pages=777-782&publication_year=2012&author=Crowley%2CMJ&author=Powers%2CBJ&author=Myers%2CER&author=McBroom%2CAJ&author=Sanders%2CG
- What's the monthly income of https://doi.org/10.1016%2Fj.pharmthera.2008.08.009?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18804122?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=AT2%20receptors%3A%20functional%20relevance%20in%20cardiovascular%20disease&journal=Pharmacol%20Ther&doi=10.1016%2Fj.pharmthera.2008.08.009&volume=120&pages=292-316&publication_year=2008&author=Jones%2CES&author=Vinh%2CA&author=McCarthy%2CCA&author=Gaspari%2CTA&author=Widdop%2CRE?
- What's the income of http://scholar.google.com/scholar_lookup?&title=AT2%20receptor%20and%20tissue%20injury%3A%20therapeutic%20implications&journal=Curr%20Hypertens%20Res&doi=10.1007%2Fs11906-013-0416-6&volume=16&pages=416-426&publication_year=2014&author=Namsolleck%2CP&author=Recarti%2CC&author=Foulquier%2CS&author=Steckelings%2CUM&author=Unger%2CT?
- Learn how profitable https://doi.org/10.1002%2Femmm.201000080 is on a monthly basis
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377325
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20597104
- How much does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20revisited%3A%20new%20roles%20in%20inflammation%2C%20immunology%20and%20aging&journal=EMBO%20Mol%20Med&doi=10.1002%2Femmm.201000080&volume=2&pages=247-257&publication_year=2010&author=Benigni%2CA&author=Cassis%2CP&author=Remuzzi%2CG rake in every month?
- Revenue of https://doi.org/10.1016%2Fj.amjmed.2008.02.038
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18691475?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20receptor%20blockers%3A%20current%20status%20and%20future%20prospects&journal=Am%20J%20Med&doi=10.1016%2Fj.amjmed.2008.02.038&volume=121&pages=656-663&publication_year=2008&author=Ram%2CCVS produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16088851 rake in every month?
- Get to know http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20receptor%20blockade%20and%20ventricular%20remodeling&journal=JRAAS&volume=6&pages=43-48&publication_year=2005&author=Anavekar%2CNS&author=Solomon%2CSD's earnings
- What are the total earnings of https://doi.org/10.1161%2F01.CIR.0000131449.94713.AD?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15173039's total income per month
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Combined%20blockade%20of%20the%20renin-angiotensin%20system%20with%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20type%201%20receptor%20antagonists&journal=Circulation&doi=10.1161%2F01.CIR.0000131449.94713.AD&volume=109&pages=2492-2499&publication_year=2004&author=Azizi%2CM&author=Menard%2CJ?
- How much does https://doi.org/10.1111%2Fbph.12313 rake in every month?
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952792
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23889512?
- Profit of http://scholar.google.com/scholar_lookup?&title=Molecular%20mechanisms%20underlying%20physiological%20and%20receptor%20pleiotropic%20effects%20mediated%20by%20GLP-1R%20activation&journal=Br%20J%20Pharmacol&doi=10.1111%2Fbph.12313&volume=171&pages=1114-1128&publication_year=2014&author=Pabreja%2CK&author=Mohd%2CMA&author=Kode%2CC&author=Wootten%2CD&author=Furness%2CSGB
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Dipeptidyl%20peptidase-4%20inhibitors%20and%20GLP-1%20reduce%20myocardial%20infarct%20size%20in%20a%20glucose-dependent%20manner&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-12-154&volume=22&publication_year=2013&author=Hausenloy%2CDJ&author=Whitington%2CHJ&author=Wynne%2CAM&author=Begum%2CSS&author=Theodorou%2CL&author=Riksen%2CN
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286367?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22234149 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Cardiovascular%20safety%20with%20linagliptin%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20a%20pre-specified%20prospective%2C%20and%20adjudicated%20mata-analysis%20of%20a%20phase%203%20programme&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-11-3&volume=11&pages=3-13&publication_year=2012&author=Johansen%2COE&author=Neubache%2CD&author=Eynatten%2CMV&author=Patel%2CS&author=Woerle%2CHJ generate monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23645229 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20dipeptidyl%20peptidase-4%20inhibitors%20in%20cardiovascular%20protection%3A%20current%20position%20and%20perspectives&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-013-6459-8&volume=27&pages=297-307&publication_year=2013&author=Wang%2CXM&author=Yang%2CYJ&author=Wu%2CYJ earn?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893610
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24410815 earning monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Optimizing%20cardioprotection%20during%20myocardial%20ischemia%3A%20targeting%20potential%20intracellular%20pathways%20with%20glucagon-like%20peptide-1&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-13-12&volume=13&pages=12-22&publication_year=2014&author=Clarke%2CSJ&author=McCormick%2CLM&author=Dutka%2CDP
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23657563
- How much does http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20receptor%20agonist%20liraglutide%20inhibits%20endothelin-1%20endothelial%20cell%20by%20repressing%20nuclear%20factor-kappa%20B%20activation&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-013-6463-z&volume=27&pages=371-380&publication_year=2013&author=Dai%2CY&author=Mehta%2CJL&author=Chen%2CM pull in?
- Learn about the earnings of https://doi.org/10.2337%2Fdb08-1193
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661586 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19151200 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=GLP-1%20receptor%20agonist%20liraglutide%20activates%20cytoprotective%20pathways%20and%20improves%20outcomes%20after%20experimental%20myocardial%20infarction%20in%20mice&journal=Diabetes&doi=10.2337%2Fdb08-1193&volume=58&pages=975-983&publication_year=2009&author=Noyan-Ashraf%2CMH&author=Momen%2CMA&author=Ban%2CK&author=Sadi%2CAM&author=Zhou%2CYQ&author=Riazi%2CAM generate?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17541736?
- How much does http://scholar.google.com/scholar_lookup?&title=Myocardial%20ischemia-reperfusion%20injury%20is%20attenuated%20by%20intact%20glucagon%20like%20peptide-1%20%28GLP-1%29%20in%20the%20in%20vitro%20rat%20heart%20and%20may%20involve%20the%20p70s6K%20pathway&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-007-6030-6&volume=21&pages=253-256&publication_year=2007&author=Bose%2CAK&author=Mocanu%2CMM&author=Carr%2CRD&author=Yellon%2CDM pull in?
- What's the financial outcome of https://doi.org/10.1093%2Fcvr%2Fcvs123?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22419668's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=GLP-1%20and%20cardioprotection%3A%20from%20bench%20to%20bedside&journal=Cardiovasc%20Res&doi=10.1093%2Fcvr%2Fcvs123&volume=94&pages=316-323&publication_year=2012&author=Ravassa%2CS&author=Zudaire%2CA&author=Diez%2CJ generate monthly?
- https://doi.org/10.1016%2Fj.yjmcc.2004.08.004's financial summary
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15522279 earn?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20AT2%20receptor%20contributes%20to%20cardiovascular%20remodeling%20of%20aged%20rats%20during%20chronic%20AT1%20receptor%20blockade&journal=J%20Mol%20Cell%20Cardiol&doi=10.1016%2Fj.yjmcc.2004.08.004&volume=37&pages=1023-1030&publication_year=2004&author=Jones%2CES&author=Black%2CMJ&author=Widdop%2CRE generate?
- Earnings of https://doi.org/10.1510%2Ficvts.2010.234773
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20650957 bring in?
- http://scholar.google.com/scholar_lookup?&title=Cardiac%20pathologies%20in%20relation%20to%20Smad-dependent%20pathways&journal=Interact%20Cardiovasc%20Thorac%20Surg&doi=10.1510%2Ficvts.2010.234773&volume=11&pages=455-460&publication_year=2010&author=Yuan%2CSM&author=Jing%2CH's financial summary
- Get to know what's the income of https://doi.org/10.1016%2Fj.cardiores.2005.07.007
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16107248 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20complex%20pattern%20of%20SMAD%20signaling%20in%20the%20cardiovascular%20system&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2005.07.007&volume=69&pages=15-25&publication_year=2006&author=Euler-Taimor%2CG&author=Heger%2CJ net monthly?
- Income figures for https://doi.org/10.1016%2Fj.cardiores.2006.10.002
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924687's financial summary
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17109837?
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20TGF-%CE%B2%20signaling%20in%20myocardial%20infarction%20and%20cardiac%20remodeling&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2006.10.002&volume=74&pages=184-195&publication_year=2007&author=Bujak%2CM&author=Frangogiannis%2CNG have?
- What's the monthly income of https://doi.org/10.1152%2Fajpheart.00910.2006?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17513491?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20collagen%20synthesis%20by%20inhibitory%20Smad7%20in%20cardiac%20myofibroblasts&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00910.2006&volume=293&pages=H1282-H1290&publication_year=2007&author=Wang%2CB&author=Omara%2CA&author=Angelovska%2CT&author=Drobic%2CV&author=Rattan%2CSG&author=Jones%2CSC
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11087260's total income per month
- http://scholar.google.com/scholar_lookup?&title=Interaction%20between%20angiotensin%20II%20and%20Smad%20proteins%20in%20fibroblasts%20in%20failing%20heart%20and%20in%20vitro&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&volume=279&pages=H3020-H3030&publication_year=2000&author=Hao%2CJM&author=Wang%2CBQ&author=Jones%2CSC&author=Jassal%2CDS&author=Dixon%2CIMC's financial summary
- How much money does https://doi.org/10.1152%2Fajpendo.00370.2004 generate?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15657092?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20marked%20attenuation%20of%20production%20of%20collagen%20type%20I%20from%20cardiac%20fibroblasts%20by%20dehydroepiandrosterone&journal=Am%20J%20Physiol%20Endocrinol%20Metab&doi=10.1152%2Fajpendo.00370.2004&volume=288&pages=E1222-E1228&publication_year=2005&author=Iwasaki%2CT&author=Mukasa%2CK&author=Yoneda%2CM&author=Ito%2CS&author=Yamada%2CY&author=Mori%2CY produce monthly?
- What's the profit of https://doi.org/10.1016%2Fj.ejphar.2008.12.049?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19374881
- Earnings of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20increases%20collagen%20I%20expression%20via%20transforming%20growth%20factor-beta1%20and%20extracellular%20signal-regulated%20kinase%20in%20cardiac%20fibroblasts&journal=Eur%20J%20Pharmacol&doi=10.1016%2Fj.ejphar.2008.12.049&volume=606&pages=115-120&publication_year=2009&author=Gao%2CXR&author=He%2CXY&author=Luo%2CB&author=Peng%2CLY&author=Lin%2CJ&author=Zuo%2CZY
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21373977's revenue stream
- Income figures for http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20infusion-induced%20inflammation%2C%20monocytic%20fibroblast%20precursor%20infiltration%20and%20cardiac%20fibrosis%20are%20pressure%20dependent&journal=Cardiovasc%20Toxicol&doi=10.1007%2Fs12012-011-9109-z&volume=11&pages=157-167&publication_year=2011&author=Qi%2CGM&author=Jia%2CL&author=Li%2CYL&author=Bian%2CY&author=Cheng%2CJZ&author=Li%2CHH
- Learn about the earnings of https://doi.org/10.1016%2Fj.ijcard.2011.12.007
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22217485?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20novel%20DPP-4%20inhibitor%20linagliptin%20and%20BI%2014361%20reduce%20infarct%20size%20after%20myocardial%20ischemia%2Freperfusion%20in%20rats&journal=Int%20J%20Cardiol&doi=10.1016%2Fj.ijcard.2011.12.007&volume=167&pages=87-93&publication_year=2013&author=Hocher%2CB&author=Sharkovska%2CY&author=Mark%2CM&author=Klein%2CT&author=Pfab%2CT rake in every month?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25022544
- Financial intake of http://scholar.google.com/scholar_lookup?&title=DPP-4%20inhibitors%20repress%20NLRP3%20inflammasome%20and%20interleukin-1beta%20via%20GLP-1%20receptor%20in%20macrophages%20through%20protein%20kinase%20C%20pathway&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-014-6539-4&volume=28&pages=425-432&publication_year=2014&author=Dai%2CY&author=Dai%2CD&author=Wang%2CXW&author=Ding%2CZF&author=Mehta%2CJL
- How profitable is https://doi.org/10.3389%2Ffendo.2013.00016?
- Get to know http://scholar.google.com/scholar_lookup?&title=Linagliptin%3A%20a%20thorough%20characterization%20beyond%20its%20clinical%20efficacy&journal=Front%20Endocrinol&doi=10.3389%2Ffendo.2013.00016&volume=4&pages=1-9&publication_year=2013&author=Sortino%2CMA&author=Sinagra%2CT&author=Canonico%2CPL's earnings
- Explore the financials of https://doi.org/10.1016%2Fj.cardiores.2006.09.006
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17049503 earns monthly
- Monthly income for http://scholar.google.com/scholar_lookup?&title=ACE2%20of%20the%20heart%3A%20from%20angiotensin%20I%20to%20angiotensin%20%281-7%29&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2006.09.006&volume=73&pages=463-469&publication_year=2007&author=Keidar%2CS&author=Kaplan%2CM&author=Gamliel%20-Lazarovich%2CA
- How much revenue does https://doi.org/10.1161%2F01.HYP.0000205833.89478.5b produce monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16505206?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Deletion%20of%20angiotensin-converting%20enzyme%202%20accelerates%20pressure%20overload-induced%20cardiac%20dysfunction%20by%20increasing%20local%20angiotensin%20II&journal=Hypertension&doi=10.1161%2F01.HYP.0000205833.89478.5b&volume=47&pages=718-726&publication_year=2006&author=Yamamoto%2CK&author=Ohishi%2CM&author=Katsuya%2CT&author=Ito%2CN&author=Ikushima%2CM&author=Kaibe%2CM?
- Revenue of https://doi.org/10.1152%2Fajpheart.00372.2006
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17213482?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Angiotensin-%281-7%29%20prevents%20diabetes-induced%20cardiovascular%20dysfunction&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00372.2006&volume=292&pages=H666-H672&publication_year=2007&author=Benter%2CIF&author=Yousif%2CMHM&author=Cojocel%2CC&author=AI-Maghrebi%2CM&author=Diz%2CDI
- Get to know https://doi.org/10.1161%2FHYPERTENSIONAHA.112.191650's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22508831 pull in monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Cardioprotective%20effects%20mediated%20by%20angiotensin%20II%20type%201%20receptor%20blockade%20and%20enhancing%20angiotensin%201-7%20in%20experimental%20heart%20failure%20in%20angiotensin-converting%20enzyme%202%20-%20null%20mice&journal=Hypertension&doi=10.1161%2FHYPERTENSIONAHA.112.191650&volume=59&pages=1195-1203&publication_year=2012&author=Patel%2CVB&author=Bodiga%2CS&author=Fan%2CD&author=Das%2CSK&author=Wang%2CZH&author=Wang%2CW
- Get to know https://doi.org/10.1152%2Fajpheart.00937.2006's earnings
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17098828 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Prevention%20of%20angiotensin%20II-induced%20cardiac%20remodeling%20by%20angiotensin-%281-7%29&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00937.2006&volume=292&pages=H736-H742&publication_year=2007&author=Grobe%2CJL&author=Mecca%2CAP&author=Lingis%2CM&author=Shenoy%2CV&author=Bolton%2CTA&author=Machado%2CJM earn?
- How much does https://doi.org/10.1210%2Fen.2013-1934 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24467746 rake in every month?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=GLP-1%20receptor%20localization%20in%20monkey%20and%20human%20tissue%3A%20novel%20distribution%20revealed%20with%20extensively%20validated%20monoclonal%20antibody&journal=Endocrinology&doi=10.1210%2Fen.2013-1934&volume=155&pages=1280-1290&publication_year=2014&author=Pyke%2CC&author=Heller%2CS&author=Kirk%2CRK&author=Orskov%2CC&author=Reedtz-Runge%2CS&author=Kaastrup%2CP?
- What's the total monthly financial gain of https://doi.org/10.1152%2Fajpheart.00347.2005?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16024574
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Active%20metabolite%20of%20GLP-1%20mediates%20myocardial%20glucose%20uptake%20and%20improves%20left%20ventricular%20performance%20in%20conscious%20dogs%20with%20dilated%20cardiomyopathy&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00347.2005&volume=289&pages=H2401-H2408&publication_year=2005&author=Nikolaidis%2CLA&author=Elahi%2CD&author=Shen%2CYT&author=Shannon%2CRP
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24048504?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Linagliptin%20alleviates%20hepatic%20steatosis%20and%20inflammation%20in%20a%20mouse%20model%20of%20non-alcoholic%20steatohepatitis&journal=Med%20Mol%20Morphol&doi=10.1007%2Fs00795-013-0053-9&volume=47&pages=137-149&publication_year=2014&author=Klein%2CT&author=Fuji%2CM&author=Sandel%2CJ&author=Shibazaki%2CY&author=Wakamatsu%2CK&author=Mark%2CM?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996354's earnings
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21080957's revenue stream
- Income figures for http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20and%20the%20exenatide%20analogue%20AC3174%20improve%20cardiac%20function%2C%20cardiac%20remodeling%2C%20and%20survival%20in%20rats%20with%20chronic%20heart%20failure&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-9-76&volume=9&pages=76-90&publication_year=2010&author=Liu%2CQ&author=Anderson%2CC&author=Broyde%2CA&author=Polizzi%2CC&author=Fernandez%2CR&author=Baron%2CA
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s10557-015-6592-7?format=refman&flavour=references?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Li-Hui%20Zhang's total income per month
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Li-Hui%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xue-Fen%20Pang generate monthly?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xue-Fen%20Pang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feng%20Bai produce monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feng%20Bai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ning-Ping%20Wang?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ning-Ping%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmed%20Ijaz%20Shah makes per month
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmed%20Ijaz%20Shah%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20J.%20McKallip's earnings
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20J.%20McKallip%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xue-Wen%20Li?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xue-Wen%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiong%20Wang pull in monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiong%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhi-Qing%20Zhao?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhi-Qing%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- What's the income generated by https://s100.copyright.com/AppDispatchServlet?title=Preservation%20of%20Glucagon-Like%20Peptide-1%20Level%20Attenuates%20Angiotensin%20II-Induced%20Tissue%20Fibrosis%20by%20Altering%20AT1%2FAT2%20Receptor%20Expression%20and%20Angiotensin-Converting%20Enzyme%202%20Activity%20in%20Rat%20Heart&author=Li-Hui%20Zhang%20et%20al&contentID=10.1007%2Fs10557-015-6592-7©right=Springer%20Science%2BBusiness%20Media%20New%20York&publication=0920-3206&publicationDate=2015-05-21&publisherName=SpringerNature&orderBeanReset=true each month?
- https://crossmark.crossref.org/dialog/?doi=10.1007/s10557-015-6592-7 income
- How much profit does https://citation-needed.springer.com/v2/references/10.1007/s10557-015-6592-7?format=refman&flavour=citation generate?
- What is the monthly revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- What's the profit of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- Explore the financials of https://www.springernature.com/gp/products
- https://www.springernature.com/gp/librarians income
- How much does https://www.springernature.com/gp/societies rake in every month?
- How much profit is https://www.springernature.com/gp/partners making per month?
- See how much https://www.springer.com/ makes per month
- Find out how much https://www.nature.com/ earns monthly
- How much revenue does https://www.biomedcentral.com/ produce monthly?
- How much profit does https://www.palgrave.com/ generate?
- How much revenue does https://www.apress.com/ produce monthly?
- Learn how profitable https://www.springernature.com/gp/legal/ccpa is on a monthly basis
- Get to know what's the income of https://www.springernature.com/gp/info/accessibility
- How much profit is https://support.springernature.com/en/support/home making per month?
- What's the profit of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Revenue of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref